ABERDEEN PROVING GROUND, Md. – Although much attention in the media of late has been focused on COVID-19 vaccine candidates, a critical element in helping the Army maintain operational readiness is ...
A proof of concept study suggests an FT-IR microspectroscopy blood test can detect a single circulating tumour cell in a lung cancer patient, supporting future real time monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback